| Type | Announcement |
| Subject | OTHERS |
| Description | Optimax Holdings Berhad ("Optimax" or "the Company") - Approval from the Ministry of Health of Malaysia (MOH) on the application for an ambulatory care centre licence pursuant to the Private Healthcare Facilities and Services Act 1998 and Private Hospitals and Other Private Healthcare Facilities Regulations 2006 to Optimax Eye Specialist Centre (Seremban) Sdn Bhd, a wholly-owned subsidiary of Optimax. |
The Board of Directors of Optimax wishes to announce that Optimax Eye Specialist Centre (Seremban) Sdn Bhd (“OESC Seremban”), a wholly-owned subsidiary of the Company, had on 18 November 2020 received a letter from the MOH dated 13 November 2020 approving OESC Seremban’s application for an ambulatory care centre licence (“Licence”) under the Private Healthcare Facilities and Services Act 1998 and Private Hospitals and Other Private Healthcare Facilities Regulations 2006. The Licence was issued with the aforesaid letter.
The Licence allows OESC Seremban to operate and provide a private ambulatory care centre known as “Optimax Seremban Eye Specialist Centre” situated at No. 141 & 142, Jalan Tun Dr. Ismail, 70200 Seremban, Negeri Sembilan with the following type of healthcare services:
The Licence shall be valid for a period of two (2) years effective from 27 October 2020 to 26 October 2022 and renewable at least six (6) months prior to the expiry of the said Licence.
The Licence will not have any material effect on the earnings per share and net assets per share of the Company and its subsidiaries for the financial year ending 31 December 2020. The Licence will not have any effect on the share capital, gearing and substantial shareholders’ shareholdings of the Company.
This announcement is dated 19 November 2020.
| Company Name | OPTIMAX HOLDINGS BERHAD |
| Stock Name | OPTIMAX |
| Date Announced | 19 Nov 2020 |
| Category | General Announcement for PLC |
| Reference Number | GA1-19112020-00014 |